Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.71 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.69 |
| ▸ | MEN1 | O00255 | 1/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.69 |
| ▸ | GNAI3 | P08754 | 9/20 | 0.66 |
| ▸ | GNAI1 | P63096 | 9/20 | 0.66 |
| ▸ | GNAO1 | P09471 | 8/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | ATM | Q13315 | 1/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | NAAA | Q02083 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10983 | 0.94 | L3MBTL1 (0.62) | L3MBTL1TDP1MEN1KMT2AGNAI3 | |
| SCHEMBL6285463 | 0.92 | L3MBTL1 (0.83) | L3MBTL1TDP1MEN1KMT2AGNAI3 | |
| SCHEMBL2134122 | 0.92 | L3MBTL1 (0.83) | L3MBTL1TDP1MEN1KMT2AGNAI3 | |
| SCHEMBL4450061 | 0.90 | L3MBTL1 (0.80) | L3MBTL1TDP1MEN1KMT2AGNAI3 | |
| SCHEMBL8972813 | 0.90 | L3MBTL1 (0.80) | L3MBTL1TDP1MEN1KMT2AGNAI3 | |
| SCHEMBL1045855 | 0.90 | L3MBTL1 (0.80) | L3MBTL1TDP1MEN1KMT2AGNAI3 | |
| SCHEMBL8972823 | 0.90 | L3MBTL1 (0.80) | L3MBTL1TDP1MEN1KMT2AGNAI3 | |
| SCHEMBL768398 | 0.90 | L3MBTL1 (0.80) | L3MBTL1TDP1MEN1KMT2AGNAI3 | |
| SCHEMBL7060548 | 0.90 | L3MBTL1 (0.80) | L3MBTL1TDP1MEN1KMT2AGNAI3 | |
| SCHEMBL8972980 | 0.90 | L3MBTL1 (0.80) | L3MBTL1TDP1MEN1KMT2AGNAI3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120208799-A1 | COMPOUNDS | RESPIVERT LTD (GB) | 2012-08-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120208799-A1 | COMPOUNDS | LTC4S, CYP11B2, LTB4R2 | L3MBTL1 4133/4885TDP1 3210/4885MEN1 1550/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.